Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $29.86.

A number of research firms have recently commented on OPCH. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Barrington Research raised their price target on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC increased its holdings in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC raised its position in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after acquiring an additional 2,757 shares during the period. Finally, Quarry LP boosted its stake in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 0.5 %

NASDAQ:OPCH opened at $29.16 on Friday. Option Care Health has a one year low of $21.39 and a one year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market cap of $4.96 billion, a PE ratio of 24.50, a P/E/G ratio of 2.44 and a beta of 1.31. The firm’s 50 day simple moving average is $23.57 and its 200 day simple moving average is $27.72.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.